FMP

FMP

Enter

QNRX - Quoin Pharmaceuticals, Ltd.

Financial Summary of Quoin Pharmaceuticals, Ltd.(QNRX), Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of thera

About

ceo

Dr. Michael Myers Ph.D.

sector

Healthcare

industry

Biotechnology

website

https://quoinpharma.com

exchange

NASDAQ

Description

Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.

CIK

0001671502

ISIN

US74907L3006

CUSIP

74907L102

Address

42127 Pleasant Forest Court

Phone

703 980 4182

Country

US

Employee

4

IPO Date

Aug 1, 2016

Summary

CIK

0001671502

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

74907L102

ISIN

US74907L3006

Country

US

Price

0.95

Beta

2.12

Volume Avg.

617.06k

Market Cap

900.13k

Shares

-

52-Week

0.8-12.0

DCF

2.67

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-0.1

P/B

-

Website

https://quoinpharma.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest QNRX News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep